1. Home
  2. FULC vs ORGN Comparison

FULC vs ORGN Comparison

Compare FULC & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • ORGN
  • Stock Information
  • Founded
  • FULC 2015
  • ORGN 2008
  • Country
  • FULC United States
  • ORGN United States
  • Employees
  • FULC N/A
  • ORGN N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • ORGN Major Chemicals
  • Sector
  • FULC Health Care
  • ORGN Industrials
  • Exchange
  • FULC Nasdaq
  • ORGN Nasdaq
  • Market Cap
  • FULC 221.5M
  • ORGN 199.7M
  • IPO Year
  • FULC 2019
  • ORGN N/A
  • Fundamental
  • Price
  • FULC $3.60
  • ORGN $1.25
  • Analyst Decision
  • FULC Hold
  • ORGN Strong Buy
  • Analyst Count
  • FULC 10
  • ORGN 1
  • Target Price
  • FULC $7.44
  • ORGN $3.00
  • AVG Volume (30 Days)
  • FULC 676.6K
  • ORGN 794.6K
  • Earning Date
  • FULC 11-13-2024
  • ORGN 11-14-2024
  • Dividend Yield
  • FULC N/A
  • ORGN N/A
  • EPS Growth
  • FULC N/A
  • ORGN N/A
  • EPS
  • FULC N/A
  • ORGN N/A
  • Revenue
  • FULC $81,630,000.00
  • ORGN $34,061,000.00
  • Revenue This Year
  • FULC $2,821.96
  • ORGN $10.62
  • Revenue Next Year
  • FULC N/A
  • ORGN $175.99
  • P/E Ratio
  • FULC N/A
  • ORGN N/A
  • Revenue Growth
  • FULC 2582.55
  • ORGN 295.97
  • 52 Week Low
  • FULC $2.87
  • ORGN $0.44
  • 52 Week High
  • FULC $13.70
  • ORGN $1.90
  • Technical
  • Relative Strength Index (RSI)
  • FULC 50.49
  • ORGN 37.39
  • Support Level
  • FULC $3.38
  • ORGN $1.24
  • Resistance Level
  • FULC $3.63
  • ORGN $1.35
  • Average True Range (ATR)
  • FULC 0.16
  • ORGN 0.06
  • MACD
  • FULC 0.12
  • ORGN -0.01
  • Stochastic Oscillator
  • FULC 87.18
  • ORGN 18.92

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About ORGN Origin Materials Inc.

Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others.

Share on Social Networks: